Nancy Folley
Family · Danville, VANPI 1154814119
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 44 manufacturers reported payments, led by AbbVie at 57.9% of the total. Reporting peaked in 2021 at $12,713 and has fallen 73.7% since, to $3,342 in 2025. Among family clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,001 payments — averaging $36.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$21K
- Biogen$2K
- EMD Serono, Inc.$1K
- Neurocrine Biosciences, Inc.$1K
- Acadia Pharmaceuticals Inc$1K
- Novartis$772
- plus $9K from 38 others
What the payments were for
- Speaking & faculty fees$19,21952%
- Travel & lodging$1790%
- Food & beverage$17,10146%
- Education$3871%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$36,886 in reported general payments places this provider in the 95th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 31 | $195,305 |
| Nurtec OdtRimegepant Sulfate | 79 | $147,040 |
| MayzentSiponimod | 12 | $114,233 |
| UbrelvyUbrogepant | 77 | $109,230 |
| QuliptaAtogepant | 87 | $106,565 |
| Austedo XrDeutetrabenazine | 16 | $95,403 |
| AptiomEslicarbazepine Acetate | 48 | $87,347 |
| Aimovig AutoinjectorErenumab-Aooe | 39 | $34,009 |
| RexultiBrexpiprazole | 23 | $33,925 |
| XcopriCenobamate | 26 | $30,929 |
| BriviactBrivaracetam | 22 | $29,713 |
| Nucynta ErTapentadol Hcl | 14 | $24,903 |
| Emgality PenGalcanezumab-Gnlm | 35 | $24,165 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 15 | $24,023 |
| Lacosamide | 89 | $10,117 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $21,375 | $215,795164 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $1,083 | $195,30531 claims |
| PfizerNurtec Odt | $488 | $147,04079 claims |
| NovartisMayzent | $772 | $114,23312 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $649 | $95,40316 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $202 | $87,34748 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $360 | $33,92523 claims |
| SK Life Science, Inc.Xcopri | $601 | $30,92926 claims |
| UCB, Inc.Briviact | $749 | $29,71322 claims |
| Corium, LLCAdlarity | $163 | $5,31512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,332 family providers in Virginia.
Other family in Danville
- Casey SharpDanville$63K
- Phyllis ScarceDanville$18K
- Edythe BoitnottDanville$11K
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.